D. Moazed, Small RNAs in transcriptional gene silencing and genome defence, Nature, vol.457, pp.413-420, 2009.

R. F. Ketting, The many faces of RNAi, Dev. Cell, vol.20, pp.148-161, 2011.

C. F. Bennett and E. E. Swayze, RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform, Annu. Rev. Pharmacol. Toxicol, vol.50, pp.259-293

P. Sazani and R. Kole, Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing, J. Clin. Invest, vol.112, pp.481-486, 2003.

J. C. Burnett, J. J. Rossi, and K. Tiemann, Current progress of siRNA/shRNA therapeutics in clinical trials, Biotechnol. J, vol.6, pp.1130-1146, 2011.

R. Kole, A. R. Krainer, and S. Altman, RNA therapeutics: beyond RNA interference and antisense oligonucleotides, Nat. Rev. Drug Discov, vol.11, pp.125-140, 2012.

A. K. Vaishnaw, J. Gollob, C. Gamba-vitalo, R. Hutabarat, D. Sah et al., A status report on RNAi therapeutics. Silence, vol.1, p.14, 2010.

J. K. Watts and D. R. Corey, Silencing disease genes in the laboratory and the clinic, J. Pathol, vol.226, pp.365-379, 2012.

K. A. Whitehead, R. Langer, and D. G. Anderson, Knocking down barriers: advances in siRNA delivery, Nat. Rev. Drug Discov, vol.8, pp.129-138, 2009.

R. Juliano, J. Bauman, H. Kang, and X. Ming, Biological barriers to therapy with antisense and siRNA oligonucleotides, Mol. Pharm, vol.6, pp.686-695, 2009.

M. H. Caruthers, A brief review of DNA and RNA chemical synthesis, Biochem. Soc. Trans, vol.39, pp.575-580, 2011.

M. E. Davis, J. E. Zuckerman, C. H. Choi, D. Seligson, A. Tolcher et al., Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles, Nature, vol.464, pp.1067-1070, 2010.

K. T. Love, K. P. Mahon, C. G. Levins, K. A. Whitehead, W. Querbes et al., Lipid-like materials for low-dose, in vivo gene silencing, Proc. Natl Acad. Sci. USA, vol.107, pp.1864-1869

A. Schroeder, C. G. Levins, C. Cortez, R. Langer, and D. G. Anderson, Lipid-based nanotherapeutics for siRNA delivery, J. Intern. Med, vol.267, pp.9-21, 2010.

Y. C. Tseng, S. Mozumdar, and L. Huang, Lipid-based systemic delivery of siRNA, Adv. Drug Deliv. Rev, vol.61, pp.721-731, 2009.

F. Szoka, Molecular biology. The art of assembly, Science, vol.319, pp.578-579, 2008.

J. Nguyen and F. C. Szoka, Nucleic acid delivery: the missing pieces of the puzzle?, Acc. Chem. Res, vol.45, pp.1153-1162, 2012.

T. Coursindel, P. Jarver, and M. J. Gait, Peptide-based in vivo delivery agents for oligonucleotides and siRNA, Nucleic Acid Ther, vol.22, pp.71-76, 2012.

A. Van-den-berg and S. F. Dowdy, Protein transduction domain delivery of therapeutic macromolecules, Curr. Opin. Biotechnol, vol.22, pp.888-893, 2011.

K. Ezzat, S. E. Andaloussi, E. M. Zaghloul, T. Lehto, S. Lindberg et al., PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation, Nucleic Acids Res, vol.39, pp.5284-5298, 2011.

J. P. Dassie, X. Y. Liu, G. S. Thomas, R. M. Whitaker, K. W. Thiel et al., Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors, Nat. Biotechnol, vol.27, pp.839-849, 2009.

M. R. Alam, X. Ming, M. Fisher, J. G. Lackey, K. G. Rajeev et al., Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA, Bioconjug. Chem, vol.22, pp.1673-1681, 2011.

T. Yamada, C. G. Peng, S. Matsuda, H. Addepalli, K. N. Jayaprakash et al., Versatile site-specific conjugation of small molecules to siRNA using click chemistry, J. Org. Chem, vol.76, pp.1198-1211, 2011.

D. Sethi, C. P. Chen, R. Y. Jing, M. L. Thakur, and E. Wickstrom, Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells, Bioconjug. Chem, vol.23, pp.158-163, 2012.

S. Akhtar, Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics, Expert Opin. Drug Metab. Toxicol, vol.6, pp.1347-1362, 2010.

R. L. Juliano, X. Ming, and O. Nakagawa, Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides, Bioconjug. Chem, vol.23, pp.147-157, 2011.

A. K. Varkouhi, M. Scholte, G. Storm, and H. J. Haisma, Endosomal escape pathways for delivery of biologicals, J. Control Release, vol.151, pp.220-228, 2011.

G. J. Doherty and H. T. Mcmahon, Mechanisms of endocytosis, Annu. Rev. Biochem, vol.78, pp.857-902, 2009.

M. T. Howes, S. Mayor, and R. G. Parton, Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis, Curr. Opin. Cell Biol, vol.22, pp.519-527, 2010.

I. A. Khalil, K. Kogure, H. Akita, and H. Harashima, Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery, Pharmacol. Rev, vol.58, pp.32-45, 2006.

A. Soraj, M. He, L. Peynshaert, K. Cousaert, J. Vercauteren et al., 2012) siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat, J. Control Release, vol.161, pp.132-141

A. Akinc, W. Querbes, S. De, J. Qin, M. Frank-kamenetsky et al., Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms, Mol. Ther, vol.18, pp.1357-1364, 2010.

X. Ming, K. Sato, and R. L. Juliano, Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes, J. Control Release, vol.153, pp.83-92, 2011.

A. Detzer and G. Sczakiel, Phosphorothioate-stimulated uptake of siRNA by mammalian cells: a novel route for delivery, Curr. Top. Med. Chem, vol.9, pp.1109-1116, 2009.

M. R. Alam, V. Dixit, H. Kang, Z. B. Li, X. Chen et al., Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis, Nucleic Acids Res, vol.36, pp.2764-2776, 2008.

M. R. Alam, X. Ming, V. Dixit, M. Fisher, X. Chen et al., The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking, Oligonucleotides, vol.20, pp.103-109, 2010.

E. Koller, T. M. Vincent, A. Chappell, S. De, M. Manoharan et al., Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes, Nucleic Acids Res, vol.39, pp.4795-4807, 2011.

M. Kortylewski, P. Swiderski, A. Herrmann, L. Wang, C. Kowolik et al., In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses, Nat. Biotechnol, vol.27, pp.925-932, 2009.

X. Ming, M. R. Alam, M. Fisher, Y. Yan, X. Chen et al., Intracellular delivery of an antisense oligonucleotide via endocytosis of a G protein-coupled receptor, Nucleic Acids Res, vol.38, pp.6567-6576, 2010.

A. H. Hutagalung and P. J. Novick, Role of Rab GTPases in membrane traffic and cell physiology, Physiol. Rev, vol.91, pp.119-149, 2011.

B. Stechmann, S. K. Bai, E. Gobbo, R. Lopez, G. Merer et al., Inhibition of retrograde transport protects mice from lethal ricin challenge, Cell, vol.141, pp.231-242, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00509058

L. Johannes and V. Popoff, Tracing the retrograde route in protein trafficking, Cell, vol.135, pp.1175-1187, 2008.

S. K. Alahari, N. M. Dean, M. H. Fisher, R. Delong, M. Manoharan et al., Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides, Mol. Pharmacol, vol.50, pp.808-819, 1996.

J. K. Taylor, Q. Q. Zhang, B. P. Monia, E. G. Marcusson, and N. M. Dean, Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli, Oncogene, vol.18, pp.4495-4504, 1999.

D. Xu, H. Kang, M. Fisher, and R. L. Juliano, Strategies for inhibition of MDR1 gene expression, Mol. Pharmacol, vol.66, pp.268-275, 2004.

J. A. Bauman, S. D. Li, A. Yang, L. Huang, and R. Kole, Anti-tumor activity of splice-switching oligonucleotides, Nucleic Acids Res, vol.38, pp.8348-8356, 2010.

M. Fisher, M. Abramov, A. Van-aerschot, D. Xu, R. L. Juliano et al., Inhibition of MDR1 expression with altritol-modified siRNAs, Nucleic Acids Res, vol.35, pp.1064-1074, 2007.

G. D. Eytan, R. Regev, G. Oren, C. D. Hurwitz, and Y. G. Assaraf, Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate, Eur. J. Biochem, vol.248, pp.104-112, 1997.

X. Ming, W. Ju, H. Wu, R. R. Tidwell, J. E. Hall et al., Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters, Drug Metab. Dispos, vol.37, pp.424-430, 2009.

K. W. Dunn, M. M. Kamocka, and J. H. Mcdonald, A practical guide to evaluating colocalization in biological microscopy, Am. J. Physiol. Cell Physiol, vol.300, pp.723-742, 2011.

B. W. Rice, M. D. Cable, and M. B. Nelson, In vivo imaging of light-emitting probes, J. Biomed. Opt, vol.6, pp.432-440, 2001.

S. V. Ambudkar, C. Kimchi-sarfaty, Z. E. Sauna, and M. M. Gottesman, P-glycoprotein: from genomics to mechanism, Oncogene, vol.22, pp.7468-7485, 2003.

C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev, vol.46, pp.3-26, 2001.

T. Decker and M. L. Lohmann-matthes, A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity, J. Immunol. Methods, vol.115, pp.61-69, 1988.

J. J. Turner, G. D. Ivanova, B. Verbeure, D. Williams, A. A. Arzumanov et al., Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells, Nucleic Acids Res, vol.33, pp.6837-6849, 2005.

D. J. Chin, G. A. Green, G. Zon, F. C. Szoka, and R. M. Straubinger, Rapid nuclear accumulation of injected oligodeoxyribonucleotides, New Biol, vol.2, pp.1091-1100, 1990.

H. Stenmark, Rab GTPases as coordinators of vesicle traffic, Nat. Rev. Mol. Cell Biol, vol.10, pp.513-525, 2009.

B. Storrie, J. White, S. Rottger, E. H. Stelzer, T. Suganuma et al., Recycling of golgi-resident glycosyltransferases through the ER reveals a novel pathway and provides an explanation for nocodazole-induced Golgi scattering, J. Cell Biol, vol.143, pp.1505-1521, 1998.

C. L. Howe, B. L. Granger, M. Hull, S. A. Green, C. A. Gabel et al., Derived protein sequence, oligosaccharides, and membrane insertion of the 120-kDa lysosomal membrane glycoprotein (lgp120): identification of a highly conserved family of lysosomal membrane glycoproteins, Proc. Natl Acad. Sci. USA, vol.85, pp.7577-7581, 1988.

Y. Wolf, S. Pritz, S. Abes, M. Bienert, B. Lebleu et al., Structural requirements for cellular uptake and antisense activity of peptide nucleic acids conjugated with various peptides, Biochemistry, vol.45, pp.14944-14954, 2006.

P. Midoux, C. Pichon, J. J. Yaouanc, and P. A. Jaffres, Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers, Br. J. Pharmacol, vol.157, pp.166-178, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00525108

G. D. Ivanova, A. Arzumanov, R. Abes, H. Yin, M. J. Wood et al., Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle, Nucleic Acids Res, vol.36, pp.6418-6428, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00374437

T. Yamamoto, M. Nakatani, K. Narukawa, and S. Obika, Antisense drug discovery and development, Future Med. Chem, vol.3, pp.339-365, 2011.

P. E. Nielsen, Gene targeting and expression modulation by peptide nucleic acids (PNA), Curr. Pharm. Des, vol.16, pp.3118-3123, 2010.

W. F. Lima, T. P. Prakash, H. M. Murray, G. A. Kinberger, W. Li et al., Single-stranded siRNAs activate RNAi in animals, Cell, vol.150, pp.883-894, 2012.

R. L. Juliano, X. Ming, and O. Nakagawa, The chemistry and biology of oligonucleotide conjugates, Acc. Chem. Res, vol.45, pp.1067-1076, 2012.

L. A. Wheeler, R. Trifonova, V. Vrbanac, E. Basar, S. Mckernan et al., Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras, J. Clin. Invest, vol.121, pp.2401-2412, 2011.

F. Zammarchi, E. De-stanchina, E. Bournazou, T. Supakorndej, K. Martires et al., Antitumorigenic potential of STAT3 alternative splicing modulation, Proc. Natl Acad. Sci. USA, vol.108, pp.17779-17784, 2011.

D. D. Young, C. M. Connelly, C. Grohmann, and A. Deiters, Small molecule modifiers of microRNA miR-122 function for the treatment of hepatitis C virus infection and hepatocellular carcinoma, J. Am. Chem. Soc, vol.132, pp.7976-7981, 2010.

G. S. Tan, C. H. Chiu, B. G. Garchow, D. Metzler, S. L. Diamond et al., Small molecule inhibition of RISC loading, ACS Chem. Biol, vol.7, pp.403-410, 2012.

W. Y. Giorgianna and D. D. Young, Development and utilization of non-coding RNA-small molecule interactions, Org. Biomol. Chem, vol.9, pp.7969-7978, 2011.

G. C. Kendall, E. I. Mokhonova, M. Moran, N. E. Sejbuk, D. W. Wang et al., Dantrolene enhances antisense-mediated exon skipping in human and mouse models of duchenne muscular dystrophy, Sci. Transl. Med, vol.4, pp.164-160, 2012.